Abstract

<h3>Objective:</h3> To determine post-stroke sleep disturbances (PSSD) by polysomnography (PSG) and compare them with patient and caregiver reported symptoms and sleep questionnaires <h3>Background:</h3> Post stroke sleep disturbances (PSSD) are common with prevalence of 70–80%. The awareness of patients and caregivers about the various sleep problems and its implications on quality of life &amp; outcome has not studied extensively. Identification can aid in optimum management and rehabilitation of post-stroke patients. <h3>Design/Methods:</h3> In a cross-sectional study, we screened post-stroke patients (between one month to one year after stroke onset) &amp; their caregivers about various sleep problems. This was done by a screening questionnaire, followed by specific sleep questionnaires (Pittsburgh sleep quality index (PSQI) and STOP BANG questionnaire). A subset of consenting patients underwent overnight PSG. The association of sleep questionnaires with PSG findings were done. <h3>Results:</h3> In the study period (January 2021 and June 2022), 103 post-stroke patients were enrolled, of which 41(39.8%) underwent PSG. While only 15.5% (16/103) patients and/or caregivers reported any sleep disorders themselves, when specifically asked about insomnia, snoring, excessive daytime sleepiness &amp; abnormal leg movements in sleep, this number increased to 60.2% (60/103). Further, a PSQI&gt;5, signifying poor sleep quality was present in 71.8% (74/103), and high risk of obstructive sleep apnea (OSA) by STOP BANG questionnaire was present in 33% (34/103). PSG showed Apnea Hypopnea Index (AHI)&gt;5 in 65.9% (27/41) patients, 39% (16/41) had periodic leg movements (PLMS) and 34.2% (14/41) had disrupted sleep. Even when patients &amp; caregivers had denied any sleep disturbances, the PSG in 29 such patients showed OSA in 62 % (18/29) and PLMS in 34.5% (10/29). <h3>Conclusions:</h3> The study provided insight into the knowledge gap between patient &amp; caregiver perceived sleep disturbances &amp; sleep questionnaires and polysomnography. Longitudinal studies are warranted in this population to assess the effect of treatment of sleep disturbances on outcomes like quality of life and stroke recurrence. <b>Disclosure:</b> Dr. Tayade has nothing to disclose. Dr. Vibha has nothing to disclose. Dr. Tripathi has nothing to disclose. Rajesh Kumar Singh has nothing to disclose. Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call